Indian regulators halt Sun Pharma eye‑drop production in Assam after recall of
Indian drug regulators ordered Sun Pharma to stop manufacturing eye‑drops at its Assam facility. The action follows the recall of 332 batches of ophthalmic products due to quality lapses. Regulators cited failures in the company's quality management system and are reviewing its compliance report.